High levels of HLA-G-EVs in breast cancers patients treated with neoadjuvant chemotherapy (NACT) correlates with a bad prognosis, whereas patients with high levels of free soluble HLA-G had better outcome. The gene discussed is HLA-G; the disease is breast cancer.